NeueHealth (NEUE) & Its Competitors Head to Head Review

NeueHealth (NYSE:NEUE) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its rivals? We will compare NeueHealth to similar businesses based on the strength of its risk, dividends, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Profitability

This table compares NeueHealth and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.11%	-1.57%	-0.01%

Earnings & Valuation

This table compares NeueHealth and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	9.49

NeueHealth’s rivals have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for NeueHealth and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1117	2564	98	2.69

NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 25.67%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.72%. Given NeueHealth’s higher probable upside, equities research analysts clearly believe NeueHealth is more favorable than its rivals.

Risk & Volatility

NeueHealth has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s rivals have a beta of 0.95, suggesting that their average share price is 5% less volatile than the S&P 500.

Institutional & Insider Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

NeueHealth rivals beat NeueHealth on 10 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.